FMC (FMC) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

FMC

NYSE•Basic Materials•Agricultural Inputs

$6.50+0.30(0.05%)Pre-market

Market Cap

$864.81M

P/S

0.3x

FMC Corporation, an agricultural sciences company, develops, markets, and sells crop protection chemicals in Latin America, North America, Europe, the Middle East, Africa, and Asia. The company offers crop protection chemicals, including insecticides, herbicides, and fungicides. It also provides biologicals, crop nutrition, and seed treatment products. It markets its products through its sales organization and alliance partners, independent distributors, and sales representatives. The company was founded in 1883 and is headquartered in Philadelphia, Pennsylvania.

How this company scores

WeakMetricSide Score: 23/100

Grade capped at D — Negative equity — the balance sheet is insolvent. Strongest: Cash & Earnings Quality (13/25); weakest: Profitability (0/25).

Profitability0/25

Growth2/25

Balance Sheet & Red Flags8/25

Cash & Earnings Quality13/25

Grade capped at D

Negative equity — the balance sheet is insolvent.

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 52.3x5y range 5.2x – 52.3x

Currently above its 15-quarter median.

P/S · 0.3x5y range 0.3x – 3.2x

Currently below its 20-quarter median.

P/B · 0.9x5y range 0.8x – 5.5x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Red Flag

Free cash flow has been negative in 4 of the last 8 quarters — earnings are not translating to cash.

Price & Volume

Market Cap $864.81M

Metrics at a Glance

as of September 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $2.81B
Q. Revenue: $105.90M
TTM EBITDA: $-2.48B
TTM Op. Income: $-2.73B
Q. Op. Income: $-1.11B
TTM Net Income: $-4.26B
Q. Net Income: $-2.07B
EPS: $-15.54
Shares Out.: $133.05M

$2.81B in TTM revenue declined 22.0% YoY, reaching $105.90M last quarter. TTM EBITDA of $-2.48B and TTM operating income of $-2.73B show growth is flowing through to the bottom line. However, net income is negative at $4.26B — growth is not yet reaching the bottom line. Across the last 8 quarters, TTM revenue has fallen for 5 consecutive quarters — a weakening trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: -379.2%
EBITDA Margin: -1011.6%
Op. Margin: -1050.2%
Net Margin: -1951.7%

Op. margin of -1050.2% is down 977.1% YoY — costs are rising relative to revenue. Net margin at -1951.7% and gross margin of -379.2% show how much of each revenue dollar survives to profit. Across the last 8 quarters, operating margin has fallen for 2 consecutive quarters — a weakening trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: N/A
P/S Ratio: 0.3x
P/B Ratio: N/A

P/S of 0.3x and P/B of 0.0x. P/S is low relative to typical market levels. Over the past year, P/E is up 0% — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $7.91B
Cash: $735.80M
Long-Term Debt: $3.95B
Book Value: $-19.40M
D/E Ratio: N/A
Debt/EBITDA: N/A

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $6.60M
TTM Free Cash Flow: $370.10M
FCF Margin: 13.1%
FCF / Net Income: -0.1

TTM FCF of $370.10M on $6.60M in operating cash flow. The FCF / Net Income ratio of -0.1x means the business consumes cash — it is not yet self-funding. Across the last 8 quarters, free cash flow has risen for 2 consecutive quarters — an improving trend.